RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Clopidogrel Added to Aspirin Reduces Stroke Risk in Atrial Fibrillation Patients Unsuitable for Vitamin K Antagonist Therapy
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 2
SP 23
OP 24
DO 10.1177/155989770902013
UL http://mdc.sagepub.com/content/9/2/23.abstract
AB For high-risk atrial fibrillation patients who are unsuitable for Vitamin K antagonist (eg, warfarin) therapy, dual antiplatelet therapy with clopidogrel and aspirin reduces the risk of major vascular events compared with aspirin alone, according to findings from the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events [ACTIVE]-A trial [NCT000249873].